Previous 10 | Next 10 |
BURBANK, CA - ( NewMediaWire ) - July 01, 2021 - Medolife Rx, Inc. ("Medolife"), a global integrated biopharmaceutical company with R&D, manufacturing, and consumer product distribution, which is a majority owned subsidiary of Quanta, Inc. (OTC PINK: QNTA), announced today that the Com...
BURBANK, Calif., June 29, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Medolife Rx, Inc. ("Medolife"), a global integrated biopharmaceutical company with R&D, manufacturing, and consumer product distribution, which is a majority owned subsidiary of Quanta, Inc. (OTC PINK: QNTA), a...
Medolife Rx, which is a majority owned subsidiary of Quanta (QNTA) announces that the Company has received FDA response relating to its Pre-IND filing on its lead drug candidate Escozine for the treatment of COVID-19.The response validated the Company’s clinical study conducted in the ...
BURBANK, Calif., June 23, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Medolife Rx, Inc. ("Medolife"), a global integrated biopharmaceutical company with R&D, manufacturing, and consumer products, which is a majority owned subsidiary of Quanta, Inc. (OTC PINK: QNTA), ann...
BURBANK, Calif., June 08, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Medolife Rx, Inc. ("Medolife"), a global integrated bioceutical company with R&D, manufacturing, and consumer product distribution, which is a majority owned subsidiary of Quanta, Inc. (OTC PINK: QNTA), today...
BURBANK, Calif., June 03, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Medolife Rx, Inc. ("Medolife"), a global integrated bioceutical company with R&D, manufacturing, and consumer product distribution, which is a majority owned subsidiary of Quanta, Inc. (OTC PINK: QNTA), ...
BURBANK, Calif., June 01, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Medolife Rx, Inc. ("Medolife"), a global integrated bioceutical company with R&D, manufacturing, and consumer product distribution, which is a majority owned subsidiary of Quanta, Inc. (OTC PINK: QNTA), ann...
Burbank, CA - ( NewMediaWire ) - May 27, 2021 - Medolife Rx, Inc. ("Medolife"), a global integrated bioceutical company with R&D, manufacturing, and consumer product distribution, which is a majority owned subsidiary of Quanta, Inc. (OTC PINK: QNTA), announced today that it successf...
Quanta (QNTA): Q1 Revenue of $0.32MGross margins remained above 90%.Cash on hand at the end of the quarter was over USD $0.3M, a substantial increase when compared to the same period in the prior year.Press Release For further details see: Quanta reports Q1 results
Burbank, CA - ( NewMediaWire ) - May 25, 2021 - Medolife Rx, Inc. ("Medolife"), a global integrated bioceutical company with R&D, manufacturing, and consumer product distribution, which is a majority owned subsidiary of Quanta, Inc. (OTC PINK: QNTA), announced today financial results for...
News, Short Squeeze, Breakout and More Instantly...
BURBANK, CA, Dec. 05, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Quanta, Inc. (the “Company”) (OTC PINK: QNTA), an applied sciences company based on a patented quantum biology platform that significantly boosts the potency and efficiency of any plant-based matter, ...
Burbank, CA - ( NewMediaWire ) - June 01, 2022 - Medolife Rx, Inc. ("Medolife"), a global integrated biotech company with R&D, manufacturing, and consumer product distribution, which is a majority owned subsidiary of Quanta, Inc. (OTC PINK: QNTA), announced today that it is in discussion...
BURBANK, CA - ( NewMediaWire ) - May 04, 2022 - Medolife Rx, Inc. ("Medolife"), a global integrated biotech company with R&D, manufacturing, and consumer product distribution, which is a majority owned subsidiary of Quanta, Inc. (OTC QB: QNTA), announced today that it has schedul...